scholarly journals Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Laura Baquedano Mainar ◽  
Sonia Sánchez Méndez ◽  
Peña Dieste Pérez ◽  
Mónica Hernández Aragón ◽  
Nicolás Mendoza Ladrón de Guevara ◽  
...  
Keyword(s):  
Health Care ◽  
Observational Study ◽  
Sexual Activity ◽  
Treatment Adherence ◽  
Menopausal Status ◽  
Treatment Compliance ◽  
Place Of Residence ◽  
Level Of Education ◽  
Genitourinary Syndrome Of Menopause ◽  
Genitourinary Syndrome

Abstract Objective To study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement. Methods Multi-center observational study including women between 35 and 75 years. An extension study of treatment adherence was conducted during the coronavirus pandemic between March and April 2020. Results A sample of 2355 women were included. Vaginal dryness was the most frequently identified symptom (74.3%). Lubricants were the best-known treatments (69.6%), followed by local estrogens (25.7%); 66% of the women did not speak to their gynecologist about sexuality. Comparative analyses were conducted according to age, menopausal status, type of menopause, place of residence, type of health care received and level of education. During the coronavirus confinement period, adherence to treatments for vulvovaginal atrophy was poor in 72.5% asked (n = 204). Reduced sexual activity (p > 0.001) and coronavirus diagnosis (p = 0.003) were significantly associated with poorer treatment compliance. Conclusions There is great lack of knowledge of the treatments used for GSM. Most women do not talk to their gynecologist about sexuality. Adherence to treatments during the coronavirus confinement has been worryingly low.

scholarly journals Knowledge and Adherence to Treatments for Genitourinary Syndrome Of Menopause in Covid-19 Pandemic: Comem-Gsm Study

2021 ◽  
Author(s):  
Laura Baquedano Mainar ◽  
Sonia Sanchez Mendez ◽  
Peña Dieste Pérez ◽  
Monica Hernandez Aragon ◽  
Nicolás Mendoza
Keyword(s):  
Health Care ◽  
Observational Study ◽  
Sexual Activity ◽  
Treatment Adherence ◽  
Menopausal Status ◽  
Treatment Compliance ◽  
Place Of Residence ◽  
Level Of Education ◽  
Genitourinary Syndrome Of Menopause ◽  
Genitourinary Syndrome

Abstract ObjectiveTo study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement.MethodsMulti-center observational study including women between 35 and 75 years. An extension study of treatment adherence was conducted during the coronavirus pandemic between March and April 2020ResultsA sample of 2355 women were included. Vaginal dryness was the most frequently identified symptom (74.3%). Lubricants were the best-known treatments (69.6%), followed by local estrogens (25.7%); 66% of the women did not speak to their gynecologist about sexuality. Comparative analyses were conducted according to age, menopausal status, type of menopause, place of residence, type of health care received and level of education. During the coronavirus confinement period, adherence to treatments for vulvovaginal atrophy was poor in 72.5% asked (n=204). Reduced sexual activity (p>0.001) and coronavirus diagnosis (p=0.003) were significantly associated with poorer treatment compliance. ConclusionsThere is great lack of knowledge of the treatments used for GSM. Most women do not talk to their gynecologist about sexuality. Adherence to treatments during the coronavirus confinement has been worryingly low.

Microablative fractional CO 2 -laser therapy and the genitourinary syndrome of menopause: An observational study

Maturitas ◽  
2016 ◽  
Vol 94 ◽  
pp. 131-136 ◽  
Author(s):  
Eleni Pitsouni ◽  
Themos Grigoriadis ◽  
Angeliki Tsiveleka ◽  
Dimitris Zacharakis ◽  
Stefano Salvatore ◽  
...  
Keyword(s):  
Observational Study ◽  
Laser Therapy ◽  
Genitourinary Syndrome Of Menopause ◽  
Genitourinary Syndrome

Cultural Sensitivity of Health Care Office Staff and Its Association With Treatment Adherence

2013 ◽  
Author(s):  
Whitney Wall ◽  
Carolyn M. Tucker ◽  
Julia Roncoroni ◽  
Jackeline Sanchez ◽  
Amna Imran ◽  
...  
Keyword(s):  
Health Care ◽  
Treatment Adherence ◽  
Cultural Sensitivity ◽  
Office Staff

Navigating the health care system: perceptions of patients with chronic pain

2009 ◽  
Vol 29 (4) ◽  
pp. 162-168
Author(s):  
AL Dewar ◽  
K Gregg ◽  
MI White ◽  
J Lander
Keyword(s):  
Health Care ◽  
Chronic Pain ◽  
Health Care System ◽  
Health Care Professionals ◽  
Primary Care Physicians ◽  
Treatment Compliance ◽  
Care Utilization ◽  
Semistructured Interviews ◽  
The Individual ◽  
Care System

A new framework is needed for patients with chronic pain and their primary care physicians that acknowledges the individual’s experiences and provides evidence-informed education and better linkages to community-based resources. This study describes the experience of 19 chronic-pain sufferers who seek relief via the health care system. Their experiences were recorded through in-depth semistructured interviews and analyzed through qualitative methods. The participants reported early optimism, then disillusionment, and finally acceptance of living with chronic pain. Both individuals with chronic pain and their health care professionals need evidence-informed resources and information on best practices to assist them to manage pain. Empathetic communication between health care professionals and individuals with chronic pain is crucial because insensitive communication negatively affects the individual, reduces treatment compliance and increases health care utilization.

Vaginal Laser Therapy for Genitourinary Syndrome of Menopause – Systematic Review

Maturitas ◽  
2021 ◽  
Author(s):  
Eduard Mension ◽  
Inmaculada Alonso ◽  
Marta Tortajada ◽  
Isabel Matas ◽  
Sílvia Gómez ◽  
...  
Keyword(s):  
Systematic Review ◽  
Laser Therapy ◽  
Genitourinary Syndrome Of Menopause ◽  
Genitourinary Syndrome

High baseline pain is associated with treatment adherence in persons diagnosed with thumb base osteoarthritis: an observational study

2021 ◽  
Author(s):  
Vicky Duong ◽  
Philippa JA Nicolson ◽  
Sarah R Robbins ◽  
Leticia A Deveza ◽  
Anne Wajon ◽  
...  
Keyword(s):  
Observational Study ◽  
Treatment Adherence ◽  
High Baseline

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)

2009 ◽  
Vol 24 (5) ◽  
pp. 287-296 ◽  
Author(s):  
J.M. Olivares ◽  
A. Rodriguez-Morales ◽  
J. Diels ◽  
M. Povey ◽  
A. Jacobs ◽  
...  
Keyword(s):  
Observational Study ◽  
Treatment Adherence ◽  
Prospective Observational Study ◽  
Clinical Symptoms ◽  
Retrospective Chart Review ◽  
Treatment Retention ◽  
Severity Scores ◽  
Long Term Treatment ◽  
Long Acting

AbstractBackgroundThe electronic Schizophrenia Treatment Adherence Registry (e-STAR) is a prospective, observational study of patients with schizophrenia designed to evaluate long-term treatment outcomes in routine clinical practice.MethodsParameters were assessed at baseline and at 3 month intervals for 2 years in patients initiated on risperidone long-acting injection (RLAI) (n = 1345) or a new oral antipsychotic (AP) (n = 277; 35.7% and 36.5% on risperidone and olanzapine, respectively) in Spain. Hospitalization prior to therapy was assessed by a retrospective chart review.ResultsAt 24 months, treatment retention (81.8% for RLAI versus 63.4% for oral APs, p < 0.0001) and reduction in Clinical Global Impression Severity scores (−1.14 for RLAI versus −0.94 for APs, p = 0.0165) were significantly higher with RLAI. Compared to the pre-switch period, RLAI patients had greater reductions in the number (reduction of 0.37 stays per patient versus 0.2, p < 0.05) and days (18.74 versus 13.02, p < 0.01) of hospitalizations at 24 months than oral AP patients.ConclusionsThis 2 year, prospective, observational study showed that, compared to oral antipsychotics, RLAI was associated with better treatment retention, greater improvement in clinical symptoms and functioning, and greater reduction in hospital stays and days in hospital in patients with schizophrenia. Improved treatment adherence, increased efficacy and reduced hospitalization with RLAI offer the opportunity of substantial therapeutic improvement in schizophrenia.

Sign in / Sign up

Export Citation Format

Share Document